Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 9139564
2-benzyl, 3-(pyrimidin-2-yl) substituted pyrazoles useful as sGC stimulators
granted -
US 9139554
Amino lipids and methods for the delivery of nucleic acids
granted -
US 9139525
N-oxide and/or di-N-oxide derivatives of dopamine receptor stabilizers/modulators displaying improved cardiovascular side-effects profiles
granted -
US 9139520
Selective androgen receptor modulators (SARMs) and uses thereof
granted -
US 9138489
Oxidized cellulose miczrospheres including visualization agents
granted -
US 9139620
Feline morbillivirus and uses thereof
granted -
US 9138453
Nutrient combinations for affecting an aging process
granted -
US 9138451
Plant extract hydrolysates and antibacterial product containing the same
granted -
US 9138447
Antimicrobial agent and method for the production thereof
granted -
US 9138457
Therapeutic modulation of ocular surface lubrication
granted -
US 9138432
Methods for the administration of iloperidone
granted -
US 9138387
Oral composition for removing tooth stain
granted -
US 9138386
Dental whitening compositions
granted -
US 9138404
Treating critically ill patients with intravenous ibuprofen
granted -
US 9138383
Nanogel materials and methods of use thereof
granted -
US 9132107
Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
granted -
US 9133480
Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructured insertion sites
granted -
US 9133478
Modified vaccinia Ankara (MVA) virus recombinants comprising heterologous coding sequences inserted into the intergenic regions between essential genes
granted -
US 9133462
dsRNA for treating viral infection
granted -
US 9133454
Method and medicament for inhibiting the expression of a given gene
granted -
US 9133461
Compositions and methods for inhibiting expression of the ALAS1 gene
granted -
US 9133250
Proteins with repetitive bacterial-Ig-like (Big) domains present in Leptospira species
granted -
US 9133253
Ricin vaccine and methods of making thereof
granted -
US 9133162
Substituted quinoline compounds and methods of use
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.